Adjunctive Therapies in the Treatment of Osteomyelitis

ABSTRACT

The current management for chronic osteomyelitis centers on adequate antibiotic coverage and surgical debridement of nonviable tissue. The eradication of osteomyelitis, however, often involves a prolonged and frustrating course of management. Nonsurgical adjunctive modalities have not been widely used, mostly due to a lack of perceived efficacy, and have remained in a state of infancy. In this article, we will outline the rationale, current status, and evidence for several potential adjuncts to osteomyelitis management.

Osteomyelitis - adjunctive therapy - hyperbaric oxygen therapy - biofilm - growth factor

REFERENCES

• 1 Lew D P, Waldvogel F A. Osteomyelitis.  Lancet. 2004;  364 369-379
• 2 Parsons B, Strauss E. Surgical management of chronic osteomyelitis.  Am J Surg. 2004;  188(Suppl) 57-66
• 3 Tice A D, Hoaglund P A, Shoultz D A. Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy.  Am J Med. 2003;  114 723-728
• 4 Lipsky B A, Berendt A R, Deery H G et al.. Diagnosis and treatment of diabetic foot infections.  Plast Reconstr Surg. 2006;  117(7, Suppl) 212S-238S
• 5 Lavery L A, Armstrong D G, Wunderlich R P, Mohler M J, Wendel C S, Lipsky B A. Risk factors for foot infections in individuals with diabetes.  Diabetes Care. 2006;  29 1288-1293
• 6 Chen C E, Shih S T, Fu T H, Wang J W, Wang C J. Hyperbaric oxygen therapy in the treatment of chronic refractory osteomyelitis: a preliminary report.  Chang Gung Med J. 2003;  26 114-121
• 7 Chen C E, Ko J Y, Fu T H, Wang C J. Results of chronic osteomyelitis of the femur treated with hyperbaric oxygen: a preliminary report.  Chang Gung Med J. 2004;  27 91-97
• 8 Gill A L, Bell C NA. Hyperbaric oxygen: its uses, mechanisms of action, and outcomes.  QJM. 2004;  97 385-395
• 9 Kawashima M, Tamura H, Nagayoshi I, Takao K, Yoshida K, Yamaguchi T. Hyperbaric oxygen therapy in orthopedic conditions.  Undersea Hyperb Med. 2004;  31 155-162
• 10 Chen X, Kidder L S, Lew W D. Osteogenic protein-1 induced bone formation in an infected segmental defect in the rat femur.  J Orthop Res. 2002;  20 142-150
• 11 Chen X, Schmidt A H, Tsukayama D T, Bourgeault C A, Lew W D. Recombinant human osteogenic protein-1 induces bone formation in a chronically infected, internally stabilized segmental defect in the rat femur.  J Bone Joint Surg Am. 2006;  88 1510-1523
• 12 Ross J J. Angiogenic gene therapy as a potential therapeutic agent in chronic osteomyelitis.  Med Hypotheses. 2006;  67 161-163
• 13 Southwood L L, Frisbie D D, Kawcak C E, Ghivizzani S C, Evans C H, McIlwraith C W. Evaluation of Ad-BMP-2 for enhancing fracture healing in an infected defect fracture rabbit model.  J Orthop Res. 2004;  22 66-72
• 14 Costerton J W. Biofilm theory can guide the treatment of device-related orthopaedic infections.  Clin Orthop Relat Res. 2005;  437 7-11
• 15 Calhoun J H, Manring M M. Adult osteomyelitis.  Infect Dis Clin North Am. 2005;  19 765-786
• 16 Vercillo M, Patzakis M J, Holtom P, Zalavras C G. Linezolid in the treatment of implant-related chronic osteomyelitis.  Clin Orthop Relat Res. 2007;  461 40-43
• 17 Mader J T, Guckian J C, Glass D L, Reinarz J A. Therapy with hyperbaric oxygen for experimental osteomyelitis due to Staphylococcus aureus in rabbits.  J Infect Dis. 1978;  138 312-318
• 18 Mader J T, Brown G L, Guckian J C, Wells C H, Reinarz J A. A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits.  J Infect Dis. 1980;  142 915-922
• 19 Mandell G L. Bactericidal activity of aerobic and anaerobic polymorphonuclear neutrophils.  Infect Immun. 1974;  9 337-341
• 20 Barth E, Sullivan T, Berg E. Animal model for evaluating bone repair with and without adjunctive hyperbaric oxygen therapy (HBO): comparing dose schedules.  J Invest Surg. 1990;  3 387-392
• 21 Hunt T K, Pai M P. The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis.  Surg Gynecol Obstet. 1972;  135 561-567
• 22 Knighton D R, Silver I A, Hunt T K. Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration.  Surgery. 1981;  90 262-270
• 23 Park M K, Myers R A, Marzella L. Oxygen tensions and infections: modulation of microbial growth, activity of antimicrobial agents, and immunologic responses.  Clin Infect Dis. 1992;  14 720-740
• 24 Verklin Jr R M, Mandell G L. Alteration of effectiveness of antibiotics by anaerobiosis.  J Lab Clin Med. 1977;  89 65-71
• 25 Bennett M H, Stanford R, Turner R. Hyperbaric oxygen therapy for promoting fracture healing and treating fracture non-union.  Cochrane Database Syst Rev. 2005;  (1) CD004712
• 26 Wang C, Schwaitzberg S, Berliner E, Zarin D A, Lau J. Hyperbaric oxygen for treating wounds: a systematic review of the literature.  Arch Surg. 2003;  138 272-279
• 27 Davis J C, Heckman J D, DeLee J C, Buckwold F J. Chronic non-hematogenous osteomyelitis treated with adjuvant hyperbaric oxygen.  J Bone Joint Surg Am. 1986;  68 1210-1217
• 28 Esterhai Jr J L, Pisarello J, Brighton C T, Heppenstall R B, Gellman H, Goldstein G. Adjunctive hyperbaric oxygen therapy in the treatment of chronic refractory osteomyelitis.  J Trauma. 1987;  27 763-768
• 29 Centers for Medicare and Medicaid Services .Medicare National Coverage Determinations Manual. 2007 Internet-only manual # 100-03 http://www.cms.hhs.gov/manuals/10m
• 30 Lentrodt S, Lentrodt J, Kubler N, Modder U. Hyperbaric oxygen for adjuvant therapy for chronically recurrent mandibular osteomyelitis in childhood and adolescence.  J Oral Maxillofac Surg. 2007;  65 186-191
• 31 Esterhai Jr J L, Pisarello J, Brighton C T, Heppenstall R B, Gellman H, Goldstein G. Adjunctive hyperbaric oxygen therapy in the treatment of chronic refractory osteomyelitis.  J Trauma. 1987;  27 763-768
• 32 Southwood L L, Frisbie D D, Kawcak C E, Ghivizzani S C, Evans C H, McIlwraith C W. Evaluation of Ad-BMP-2 for enhancing fracture healing in an infected defect fracture rabbit model.  J Orthop Res. 2004;  22 66-72
• 33 Costerton J W, Stewart P S, Greenberg E P. Bacterial biofilms: a common cause of persistent infections.  Science. 1999;  284 1318-1322
• 34 Gristina A G, Oga M, Webb L X, Hobgood C D. Adherent bacterial colonization in the pathogenesis of osteomyelitis.  Science. 1985;  228 990-993
• 35 Mayberry-Carson K J, Tober-Meyer B, Smith J K, Lambe Jr D W, Costerton J W. Bacterial adherence and glycocalyx formation in osteomyelitis experimentally induced with Staphylococcus aureus.  Infect Immun. 1984;  43 825-833
• 36 Monzon M, Garcia-Alvarez F, Lacleriga A et al.. A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment.  J Orthop Res. 2001;  19 820-826
• 37 Dell'Acqua G, Giacometti A, Cirioni O et al.. Suppression of drug-resistant Staphylococcal infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide.  J Infect Dis. 2004;  190 318-320
• 38 Cirioni O, Giacometti A, Ghiselli R et al.. Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides.  Circulation. 2003;  108 767-771
• 39 Balaban N, Collins L V, Cullor J S et al.. Prevention of diseases caused by Staphylococcus aureus using the peptide RIP.  Peptides. 2000;  21 1301-1311
• 40 Nelson F R, Brighton C T, Ryaby J et al.. Use of physical forces in bone healing.  J Am Acad Orthop Surg. 2003;  11 344-354
• 41 Guerkov H H, Lohmann C H, Liu Y et al.. Pulsed electromagnetic fields increase growth factor release by nonunion cells.  Clin Orthop Relat Res. 2001;  384 265-279
• 42 Nagai M, Ota M. Pulsating electromagnetic field stimulates mRNA expression of bone morphogenetic protein-2 and -4.  J Dent Res. 1994;  73 1601-1605
• 43 Rubin C, Bolander M, Ryaby J P, Hadjiargyrou M. The use of low-intensity ultrasound to accelerate the healing of fractures.  J Bone Joint Surg Am. 2001;  83 259-270
• 44 Parvizi J, Wu C C, Lewallen D G, Greenleaf J F, Bolander M E. Low-intensity ultrasound stimulates proteoglycan synthesis in rat chondrocytes by increasing aggrecan gene expression.  J Orthop Res. 1999;  17 488-494
• 45 Yang K H, Parvizi J, Wang S J et al.. Exposure to low-intensity ultrasound increases aggrecan gene expression in a rat femur fracture model.  J Orthop Res. 1996;  14 802-809
• 46 Rawool N M, Goldberg B B, Forsberg F, Winder A A, Hume E. Power Doppler assessment of vascular changes during fracture treatment with low-intensity ultrasound.  J Ultrasound Med. 2003;  22 145-153
• 47 Ehrlich G D, Stoodley P, Kathju S et al.. Engineering approaches for the detection and control of orthopaedic biofilm infections.  Clin Orthop Relat Res. 2005;  437 59-66
• 48 McLeod B R, Fortun S, Costerton J W, Stewart P S. Enhanced bacterial biofilm control using electromagnetic fields in combination with antibiotics.  Methods Enzymol. 1999;  310 656-670
• 49 Eppley B L, Pietrzak W S, Blanton M. Platelet-rich plasma: a review of biology and applications in plastic surgery.  Plast Reconstr Surg. 2006;  118 147e-159e
• 50 Liu Y, Kalen A, Risto O, Wahlstrom O. Fibroblast proliferation due to exposure to a platelet concentrate in vitro is pH dependent.  Wound Repair Regen. 2002;  10 336-340
• 51 Marx R E. Platelet-rich plasma: evidence to support its use.  J Oral Maxillofac Surg. 2004;  62 489-496